Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents
Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Summary
The aim of the study is to evaluate the safety and efficacy of Ecnoglutide injection in overweight or obese Chinese adolescents
Official title: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Safety and Efficacy of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents (SLIMMER-YOUNG)
Key Details
Gender
All
Age Range
12 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
192
Start Date
2026-10-31
Completion Date
2028-09-30
Last Updated
2026-09-23
Healthy Volunteers
No
Interventions
Ecnoglutide Injection
Subcutaneous injection
placebo with matching volume
Subcutaneous injection
Locations (1)
Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China